Tag: InVivo Therapeutics
InVivo Therapeutics
InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries.
By modulating the healing environment...
InVivo Therapeutics scaffold device may improve spinal cord injury — 4 key insights
An investigational scaffold device from InVivo Therapeutics increases the likelihood that a patient with acute thoracic complete spinal cord injury will have a neurologic...
Using a Mini-Scaffold to Help Treat Spinal Cord Injury
Patients suffering from complete spinal cord injuries have little to no treatment options that provide meaningful improvement in patient outcomes.
Cambridge, Mass.-based InVivo Therapeutics is...
Experimental scaffold hasn’t reversed her paralysis, but she’s embraced life ‘with wheels as legs’
Jesi Stracham used to captivate biotech investors and inadvertently move markets with social media posts documenting her dogged quest to get out of her wheelchair...
The Year in Review: SCI Research Breakthroughs in 2015
As we cross the threshold into 2016, we are one step closer to our goal of finding a cure for paralysis.
Moving full speed ahead...
A shattering crash, an online chronicle, and an unexpected twist
In the age of social media, patients who test experimental treatments wield surprising clout.
The tweets and the selfies, the uploaded video clips, felt like a natural way for Jesi Stracham to record her halting progress as she fought to recover from a motorcycle accident that had left her paralyzed from the chest down.
She had no idea, as she tapped away at her iPhone from her hospital bed, what her bubbly posts would unleash.
The Race To Treat Spinal Cord Injury: A Comparative Analysis
Summary
Four biotech companies are pursuing the treatment of spinal cord injury with the use of stem cell transplantation.
Each company demonstrated efficacy in pre-clinical studies.
The...
First 2 spinal cord injury patients progress after InVivo’s Neuro-Spinal Scaffold — 5 key...
The first two patients to receive InVivo's Neuro-Spinal Scaffold for spinal cord injury are showing improvement three-to-six months after surgery.
The first spinal cord injury...
InVivo’s Neuro-Spinal Scaffold used for 2nd spinal cord injury patient
InVivo Therapeutics enrolled the second patient in their Neuro-Spinal Scaffold to treat traumatic spinal cord injury.
The patient is enrolled at Carolinas Medical Center, part...
InVivo Therapeutics Initiates First Clinical Trial of Neuro-Spinal Scaffold
Scaffold Designed to Facilitate Neural Growth in Spinal Cord Injury
CAMBRIDGE, Mass.--(BUSINESS WIRE)--April 28, 2014-- InVivo Therapeutics Holdings Corp. (NVIV) announced today that it has...
